TREE NEWS update: Since 2026, 17 biotech companies have listed on HKEX, raising HK$18.501 billion, accounting for 16.19% of the 105 new listings. Meanwhile, 110 biotech firms filed for Hong Kong IPOs this year, covering oncology, CGT, radiopharma, ophthalmology, and medical devices. A notable trend: many A-share drugmakers pursue dual listings, with some making repeated filings.
Biotech firms flock to Hong Kong IPO, ‘A+H’ listing favored
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
4m ago
Jiangxi upgrades flood orange alert as Ganjiang surges
5m ago
Visegrad states urge EU action on severe drought
7m ago
China Development Bank issues 5bn yuan green bond via online bookbuilding
39m ago
US State Dept approves arms sales to Saudi Arabia and Oman
42m ago
China Auto Dealers Assoc: Aug auto consumption index 82.7
42m ago
China Auto Dealers Assoc: August Auto Consumption Index at 82.7